Australia markets closed

Syngen Biotech Co.,Ltd. (8279.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD
Add to watchlist
150.00-1.00 (-0.66%)
At close: 11:31AM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,860,643
1,837,185
1,930,594
1,471,266
1,311,436
Cost of revenue
1,218,811
1,193,267
1,242,442
942,926
816,023
Gross profit
641,832
643,918
688,152
528,340
495,413
Operating expenses
Research development
48,469
46,756
45,323
49,517
43,417
Selling general and administrative
314,497
302,882
262,633
197,019
194,505
Total operating expenses
362,966
349,638
307,956
246,536
237,922
Operating income or loss
278,866
294,280
380,196
281,804
257,491
Interest expense
9,167
8,860
5,071
3,208
2,466
Income before tax
315,384
333,802
396,415
295,493
263,375
Income tax expense
53,725
58,975
75,179
57,723
47,825
Income from continuing operations
261,659
274,827
321,236
237,770
215,550
Net income
261,659
274,827
321,236
237,770
215,550
Net income available to common shareholders
261,659
274,827
321,236
237,770
215,550
Basic EPS
10.57
10.14
11.85
8.77
7.95
Diluted EPS
10.56
10.13
11.84
8.76
7.94
Basic average shares
27,103
27,101
27,101
27,101
27,101
Diluted average shares
27,137
27,128
27,131
27,132
27,134